Diagnostic imaging services are severely constrained for patients at the University of Pet Oncology, with PET/CT scans reportedly unavailable for several months. This shortage directly impacts the ability of medical teams to assess treatment efficacy, forcing critical treatment decisions into uncertainty. As a result, patients are compelled to seek necessary diagnostic procedures either in foreign countries or at private facilities, where the cost for a single scan can reach approximately 1,300 euros.
The difficulty in accessing essential diagnostic tools has prompted significant concern within the medical community. A patient confirmed the reality of this delay, noting an inability to undergo a PET/CT scan for a period of three months. Beyond the imaging crisis, the hematological oncology association has issued repeated warnings to the Ministry of Health regarding critical shortages of necessary oncological drugs.
The association has indicated its intent to organize protests until the Ministry implements a comprehensive solution addressing these supply gaps. These systemic failures place the burden of care and diagnosis heavily on the patients. The inability to conduct timely PET scans and the ongoing drug shortages represent a significant challenge to cancer care standards, requiring urgent intervention from health authorities to ensure continuity of care for all affected patients.
Topics: #patients #pet #scans
